Inhibition by Cholesterol Oxides of NO Release From Human Vascular Endothelial Cells

From the Laboratoire de Pharmacologie, URA CNRS 1482, Université Paris V, Faculté de Médecine Necker, Paris (A.B., F.L., E.M.-van B., M.D.-D., M.-A.D.), and the Laboratoire de Biochimie des Lipoprotéines, INSERM U498, Faculté de Médecine, Dijon (V.D., G.L., S.M., L.L., P.G.), France.

Correspondence to Marie-Aude Devynck, Laboratoire de Pharmacologie, URA CNRS 1482, Université Paris V, Faculté de Médecine Necker, Paris, France.

Abstract—Recent studies have demonstrated that, unlike cholesterol, cholesterol oxidized at position 7 can reduce the maximal endothelium-dependent relaxation of isolated rabbit aortas (Circulation. 1997;95:723–731). The aim of the current study was to determine whether cholesterol oxides reduce the release of nitric oxide (NO) from human umbilical vein endothelial cells (HUVECs). The amount of NO released by histamine-stimulated HUVECs was determined by differential pulse amperometry using a nickel porphyrin– and Nafion-coated carbon microfiber electrode. The effects of cholesterol (preserved from oxidation by butylated hydroxytoluene), 7-ketocholesterol, 7ß-hydroxycholesterol, 5,6-epoxycholesterol, 19-hydroxycholesterol (60 µg/mL), and -lysophosphatidylcholine (10 µg/mL) were compared. Pretreatment of HUVECs with cholesterol, 5,6-epoxycholesterol, or 19-hydroxycholesterol did not alter histamine-activated NO production. In contrast, pretreatment with 7-ketocholesterol or 7ß-hydroxycholesterol significantly decreased NO release. The inhibitory effect of 7-ketocholesterol was time and dose dependent and was maintained in the presence of L-arginine. In the absence of serum, lysophosphatidylcholine also reduced NO production. In ionomycin-stimulated cells, pretreatment with 7-ketocholesterol did not inhibit NO release. These results demonstrate that cholesterol derivatives oxidized at the 7 position, the main products of low density lipoprotein oxidation, reduce histamine-activated NO release in HUVECs. Such an inhibitory effect of cholesterol oxides may account, at least in part, for the ability of oxidized low density lipoprotein to reduce the endothelium-dependent relaxation of arteries.

Key Words: human endothelial cells • cholesterol oxides • histamine • NO production

This article has been cited by other articles:

				L. Persegol, B. Verges, P. Gambert, and L. Duvillard Inability of HDL from abdominally obese subjects to counteract the inhibitory effect of oxidized LDL on vasorelaxation J. Lipid Res., June 1, 2007; 48(6): 1396 - 1401. [Abstract] [Full Text] [PDF]

				H. N. Hodis, S. Hashimoto, W. J. Mack, and A. Sevanian Probucol Reduces Oxysterol Formation in Hypertensive Rabbits Hypertension, September 1, 2000; 36(3): 436 - 441. [Abstract] [Full Text] [PDF]

				K. J. Williams, R. Scalia, K. D. Mazany, W. V. Rodrigueza, and A. M. Lefer Rapid Restoration of Normal Endothelial Functions in Genetically Hyperlipidemic Mice by a Synthetic Mediator of Reverse Lipid Transport Arterioscler. Thromb. Vasc. Biol., April 1, 2000; 20(4): 1033 - 1039. [Abstract] [Full Text] [PDF]

				G. J. Schroepfer Jr. Oxysterols: Modulators of Cholesterol Metabolism and Other Processes Physiol Rev, January 1, 2000; 80(1): 361 - 554. [Abstract] [Full Text] [PDF]

				V. Deckert, G. Lizard, N. Duverger, A. Athias, V. Palleau, F. Emmanuel, M. Moisant, P. Gambert, C. Lallemant, and L. Lagrost Impairment of Endothelium-Dependent Arterial Relaxation By High-Fat Feeding in ApoE-Deficient Mice : Toward Normalization By Human ApoA-I Expression Circulation, September 14, 1999; 100(11): 1230 - 1235. [Abstract] [Full Text] [PDF]

				J. X. Rong, L. Shen, Y. H. Chang, A. Richters, H. N. Hodis, and A. Sevanian Cholesterol Oxidation Products Induce Vascular Foam Cell Lesion Formation in Hypercholesterolemic New Zealand White Rabbits Arterioscler. Thromb. Vasc. Biol., September 1, 1999; 19(9): 2179 - 2188. [Abstract] [Full Text] [PDF]

				A. M Dart and J. P.F Chin-Dusting Lipids and the endothelium Cardiovasc Res, August 1, 1999; 43(2): 308 - 322. [Abstract] [Full Text] [PDF]

				C. DESRUMAUX, V. DECKERT, A. ATHIAS, D. MASSON, G. LIZARD, V. PALLEAU, P. GAMBERT, and L. LAGROST Plasma phospholipid transfer protein prevents vascular endothelium dysfunction by delivering {alpha}-tocopherol to endothelial cells FASEB J, May 1, 1999; 13(8): 883 - 892. [Abstract] [Full Text]

				A. Nuszkowski, R. Grabner, G. Marsche, A. Unbehaun, E. Malle, and R. Heller Hypochlorite-modified Low Density Lipoprotein Inhibits Nitric Oxide Synthesis in Endothelial Cells via an Intracellular Dislocalization of Endothelial Nitric-oxide Synthase J. Biol. Chem., April 20, 2001; 276(17): 14212 - 14221. [Abstract] [Full Text] [PDF]